Cited 0 times in
Clinical characteristics of lupus myocarditis in Korea.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, JW | - |
dc.contributor.author | Joe, DY | - |
dc.contributor.author | Park, HJ | - |
dc.contributor.author | Kim, HA | - |
dc.contributor.author | Park, HS | - |
dc.contributor.author | Suh, CH | - |
dc.date.accessioned | 2010-12-23T02:22:41Z | - |
dc.date.available | 2010-12-23T02:22:41Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0172-8172 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/777 | - |
dc.description.abstract | Clinically important myocarditis is an unusual feature in systemic lupus erythematosus (SLE). We describe the clinical characteristics, management and outcomes of five SLE patients who developed severe left ventricular dysfunction. Four patients were female with mean age of 36.4 years. Three patients had both lupus myocarditis and lupus nephritis. Four patients had raised anti-dsDNA antibody titer and low complement level and two patients had positive IgG anticardiolipin antibody. Three patients were treated by high-dose corticosteroids, one patient by intravenous pulse methylprednisolone, and one patient by intravenous immunoglobulin and pulse cyclophosphamide with high dose corticosteroids. Left ventricular function improved markedly in four patients and all of them had no recurrence of lupus myocarditis up to follow-up of 33 months. However, one patient, who showed no improvement of left ventricular function, was expired due to sudden cardiac arrest. Lupus myocarditis should be treated by immunosuppressive therapy with high-dose corticosteroids and mostly the prognosis might be good with early treatment. | - |
dc.language.iso | en | - |
dc.subject.MESH | Adrenal Cortex Hormones | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Cyclophosphamide | - |
dc.subject.MESH | Death, Sudden, Cardiac | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunoglobulins, Intravenous | - |
dc.subject.MESH | Immunosuppressive Agents | - |
dc.subject.MESH | Korea | - |
dc.subject.MESH | Lupus Erythematosus, Systemic | - |
dc.subject.MESH | Lupus Nephritis | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Methylprednisolone | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Myocarditis | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Ventricular Dysfunction, Left | - |
dc.subject.MESH | Young Adult | - |
dc.title | Clinical characteristics of lupus myocarditis in Korea. | - |
dc.type | Article | - |
dc.identifier.pmid | 17634899 | - |
dc.contributor.affiliatedAuthor | 김, 현아 | - |
dc.contributor.affiliatedAuthor | 박, 해심 | - |
dc.contributor.affiliatedAuthor | 서, 창희 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1007/s00296-007-0414-6 | - |
dc.citation.title | Rheumatology international | - |
dc.citation.volume | 28 | - |
dc.citation.number | 3 | - |
dc.citation.date | 2008 | - |
dc.citation.startPage | 275 | - |
dc.citation.endPage | 280 | - |
dc.identifier.bibliographicCitation | Rheumatology international, 28(3). : 275-280, 2008 | - |
dc.identifier.eissn | 1437-160X | - |
dc.relation.journalid | J001728172 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.